The Lancet Respiratory Medicine in conversation with

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

The Lancet Group

Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv